Showing codes J7521 (Tacrolimus, granules, oral suspension, 0.1 mg) — J7637 (Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram)

J7521 - Tacrolim granules oral susp
Long description: Tacrolimus, granules, oral suspension, 0.1 mg
Code added date: 20250401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7525 - Tacrolimus injection
Long description: Tacrolimus, parenteral, 5 mg
Code added date: 20010101.
Code effective date: 20010101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7527 - Oral everolimus
Long description: Everolimus, oral, 0.25 mg
Code added date: 20130101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7599 - Immunosuppressive drug noc
Long description: Immunosuppressive drug, not otherwise classified
Code added date: 19960101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7601 - Ensifentrine inh 3 mg
Long description: Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7604 - Acetylcysteine comp unit
Long description: Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7605 - Arformoterol non-comp unit
Long description: Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7606 - Formoterol fumarate, inh
Long description: Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
Code added date: 20090101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7607 - Levalbuterol comp con
Long description: Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7608 - Acetylcysteine non-comp unit
Long description: Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
Code added date: 20000101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7609 - Albuterol comp unit
Long description: Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7610 - Albuterol comp con
Long description: Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7611 - Albuterol non-comp con
Long description: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
Code added date: 20050101.
Code effective date: 20090701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7612 - Levalbuterol non-comp con
Long description: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
Code added date: 20050101.
Code effective date: 20090701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7613 - Albuterol non-comp unit
Long description: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
Code added date: 20050101.
Code effective date: 20090701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7614 - Levalbuterol non-comp unit
Long description: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
Code added date: 20050101.
Code effective date: 20090701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7615 - Levalbuterol comp unit
Long description: Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7620 - Albuterol ipratrop non-comp
Long description: Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
Code added date: 20060101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7622 - Beclomethasone comp unit
Long description: Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20020101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7624 - Betamethasone comp unit
Long description: Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20020101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7626 - Budesonide non-comp unit
Long description: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
Code added date: 20020101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7627 - Budesonide comp unit
Long description: Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
Code added date: 20060101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7628 - Bitolterol mesylate comp con
Long description: Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7629 - Bitolterol mesylate comp unt
Long description: Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7631 - Cromolyn sodium noncomp unit
Long description: Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
Code added date: 20000101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7632 - Cromolyn sodium comp unit
Long description: Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7633 - Budesonide non-comp con
Long description: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
Code added date: 20030101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7634 - Budesonide comp con
Long description: Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7635 - Atropine comp con
Long description: Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7636 - Atropine comp unit
Long description: Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7637 - Dexamethasone comp con
Long description: Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF